32
Participants
Start Date
May 19, 2017
Primary Completion Date
March 14, 2019
Study Completion Date
December 19, 2019
COR-001
Anti-inflammatory therapy
Placebo
Sterile water with a final buffer of 25 mM Histidine, 8.5% (w/v) trehalose and 0.05% PS80
University of Coloardo Anschutz Medical Campus, Aurora
Collaborators (1)
Corvidia Therapeutics
INDUSTRY
University of Colorado, Denver
OTHER